| Field | Specification |
|---|---|
| Target | |
| Species | |
| Reactivity | |
| Applications | |
| Assay type | |
| Sample type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Detection range | |
| Detection wavelength | |
| Assay time | |
| Catalog no. (Mfr.) | |
| Main SKU |
Background
asymmetrical dimethylarginine(ADMA) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
Biological context
Researchers often monitor asymmetrical dimethylarginine(ADMA) in serum, plasma, and tissue homogenates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in asymmetrical dimethylarginine(ADMA) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that asymmetrical dimethylarginine(ADMA) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Klotho protein alleviates heart ischemia/reperfusion injury and oxidative stress through regulation of the NOS/MMP pathway
A Olejnik, A Krzywonos-Zawadzka, I Sambor,Scientific Reports,2025
L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi
Carbajosa S,PLoS neglected tropical diseases,2023
Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury
A Krzywonos-Zawadzka,Cardiol Res Pract.,2020
Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury
Krzywonos-Zawadzka A, et al,Journal Of Cellular And Molecular Medicine,2019
Protective Effects of Low Dose Rosuvastatin on Isoproterenol-induced Chronic Heart Failure in Rats by Regulation of DDAH-ADMA-NO Pathway
Ru Zhou.et al,Cardiovascular Therapeutics,2016
Comparative Effect
Mutlu E.et al,Clinical & Experimental Pharmacology,2015
Regulation of endothelial nitric oxide synthase and asymmetric dimethylarginine by matrine attenuates isoproterenol-induced acute myocardial injury in rats
/,Journal of pharmacy and pharmacology,2012